SAN DIEGO, Aug. 2, 2017 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP (J&W) has launched an investigation into whether the board members of PharMerica Corporation (NYSE: PMC) ("PharMerica") breached their fiduciary duties in connection with the proposed sale of the Company to KKR; Walgreens Boots Alliance, Inc. will also make a minority investment in the Company. PharMerica operates as an institutional pharmacy services company in the United States. The company offers services to healthcare facilities; pharmacy management services to hospitals; specialty infusion services to patients outside hospitals; and oncology pharmacy services. On August 2, 2017, PharMerica announced it had signed a definitive merger agreement with KKR. Under the terms of the agreement, PharMerica shareholders will receive $29.25 in cash for each share of PharMerica common stock upon closing of the proposed transaction.